Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Jun 30, 2025. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 51
- −3 vs. Q2 2023
- Portfolio value
- $117.7M
- −$15.7M (−11.8%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 716,297 | $41.6M | 35.3% | −12,288−1.7% | Reduced | History |
| BDSXBiodesix Inc | COM | 5,348,273 | $8.74M | 7.4% | +308,640+6.1% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 77,240 | $8.69M | 7.4% | −7,000−8.3% | Reduced | History |
| PRTAProthena Corp Public Ltd Co | SHS | 169,574 | $8.18M | 7.0% | +13,463+8.6% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 240,400 | $5.01M | 4.3% | −9,000−3.6% | Reduced | History |
| QDELQuidelOrtho Corp | COM | 65,203 | $4.76M | 4.0% | 00.0% | Unchanged | History |
| OVVOvintiv Inc. | COM | 84,200 | $4.01M | 3.4% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 190,000 | $3.02M | 2.6% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 11,000 | $2.48M | 2.1% | −4,000−26.7% | Reduced | History |
| ELUTElutia Inc. | CL A COM | 1,655,184 | $2.37M | 2.0% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 150,000 | $2.16M | 1.8% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 82,700 | $1.54M | 1.3% | 00.0% | Unchanged | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.40M | 1.2% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 455,200 | $1.38M | 1.2% | +206,000+82.7% | Added | History |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $1.36M | 1.2% | 00.0% | Unchanged | History |
| MASIMasimo Corp | COM | 15,280 | $1.34M | 1.1% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 264,843 | $1.32M | 1.1% | 00.0% | Unchanged | History |
| AXDXAccelerate Diagnostics, Inc | COM | 225,239 | $1.30M | 1.1% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
| INBXInhibrx Biosciences, Inc. | COM | 70,448 | $1.29M | 1.1% | 00.0% | Unchanged | History |
| ETRNMidstream Co LLC | COM | 133,050 | $1.25M | 1.1% | 00.0% | Unchanged | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 80,000 | $1.04M | 0.9% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 26,400 | $916.9K | 0.8% | 00.0% | Unchanged | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $872.3K | 0.7% | 00.0% | Unchanged | History |
| TXG10x Genomics, Inc. | CL A COM | 21,000 | $866.3K | 0.7% | +9,000+75.0% | Added | History |
| AXGNAxogen, Inc. | COM | 173,000 | $865.0K | 0.7% | +133,000+332.5% | Added | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 571,832 | $766.3K | 0.7% | +280,500+96.3% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 25,000 | $736.5K | 0.6% | 00.0% | Unchanged | History |
| TVTXTravere Therapeutics, Inc. | COM | 82,000 | $733.1K | 0.6% | +42,000+105.0% | Added | History |
| DCGODocGo Inc. | COM | 130,000 | $692.9K | 0.6% | +20,000+18.2% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 18,000 | $684.7K | 0.6% | +6,000+50.0% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 38,000 | $633.8K | 0.5% | 00.0% | Unchanged | History |
| SILKSilk Road Medical Inc | COM | 41,294 | $619.0K | 0.5% | +21,294+106.5% | Added | History |
| PGNYProgyny, Inc. | COM | 18,000 | $612.4K | 0.5% | +9,000+100.0% | Added | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $521.1K | 0.4% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 40,000 | $385.2K | 0.3% | 00.0% | Unchanged | History |
| HALOHalozyme Therapeutics, Inc. | COM | 10,000 | $382.0K | 0.3% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 10,000 | $341.6K | 0.3% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 28,000 | $340.5K | 0.3% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 85,000 | $334.9K | 0.3% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 2,500 | $303.1K | 0.3% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 15,000 | $294.6K | 0.3% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 12,300 | $247.8K | 0.2% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 59,833 | $234.5K | 0.2% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 25,114 | $227.3K | 0.2% | 00.0% | Unchanged | History |
| KROSKeros Therapeutics, Inc. | COM | 7,000 | $223.2K | 0.2% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 209,088 | $174.1K | 0.1% | +110,000+111.0% | Added | History |
| GTHXG1 Therapeutics, Inc. | COM | 120,000 | $172.8K | 0.1% | +80,000+200.0% | Added | History |
| IFRXInflaRx N.V. | COM | 50,000 | $149.0K | 0.1% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 20,000 | $141.6K | 0.1% | 00.0% | Unchanged | History |
| NKTRNektar Therapeutics | COM | 28,000 | $16.7K | <0.1% | 00.0% | Unchanged | History |
| YTENYIELD10 Bioscience, Inc. | COM | 18,750 | $6.13K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2023 (3)
Positions held at the end of Q2 2023 that are gone from this filing.